InvestorsHub Logo
Followers 11
Posts 1455
Boards Moderated 0
Alias Born 02/01/2013

Re: thewind post# 9946

Tuesday, 04/25/2017 10:02:55 AM

Tuesday, April 25, 2017 10:02:55 AM

Post# of 10487
By the way, if ONVO's TOX testing is far and away a more superior method of ensuring a drug will pass human clinical trials, which all evidence points to that being the case, then the future success or failure of Organovo is likely of far lessor concern to some big pharma, than what would be saving billions right now by preventing a failed clinical trial, by using this superior testing method.
Let big pharma keep their short sighted time horizon, as ONVO moves ever closer to their stated goal of creating replacement tissue for human transplant without the need for rejection meds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News